‹ All Posts
Ketan Mittal (SEBI RA)

2nd Jan · SEBI-Registered Analyst

SRF

SRF continues to strengthen its leadership in specialty chemicals and packaging films. Strong demand from pharma, agrochemicals, and refrigerants supports earnings visibility. The company’s capex pipeline enhances long-term growth prospects. However, near-term margin pressure due to pricing normalization should be tracked. SRF remains a high-quality chemicals play with strong execution and global clientele.

#PersonalFinance#Miscellaneous#MacroViews#PsychologyofMoney#EquityResearch